Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Founded in 2005, Coben Group was designed and built according to GMP standard with a total area of 100,000M2, a member of ZJMI Group-Global Fortune 500, Ranked No.270 in 2018. Coben is specialized in developing and manufacturing of APIs and intermediates for anti-virus drugs(HIV,HBV,HCV). Main products include:Lamivudine, Tenofovir, Zidovudine, Emtricitabine, Telbivudine, Oseltamivir phosphate, Gemcitabine, Sofosbuvir , Aba...
Founded in 2005, Coben Group was designed and built according to GMP standard with a total area of 100,000M2, a member of ZJMI Group-Global Fortune 500, Ranked No.270 in 2018. Coben is specialized in developing and manufacturing of APIs and intermediates for anti-virus drugs(HIV,HBV,HCV). Main products include:Lamivudine, Tenofovir, Zidovudine, Emtricitabine, Telbivudine, Oseltamivir phosphate, Gemcitabine, Sofosbuvir , Abacavir and their intermediates. Coben is hi-tech enterprises, owning provincial R&D center. Most of the products are self-developed. We hold national and international patents for many product.

List your booth number for exhibitions, ask us